Ensysce Biosciences, Inc. (ENSC) vs Femasys Inc. (FEMY)
A side-by-side comparison of Ensysce Biosciences, Inc. and Femasys Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENSC
Ensysce Biosciences, Inc.
$0.43HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
FEMY
Femasys Inc.
$2.07HealthcareDelayed quote: Oct 6, 2026, 1:41 PM EDT
Total return — ENSC vs FEMY
growth of $100 · dividends reinvested · last 5yENSC -100.0% (-90.2%/yr)FEMY -99.2% (-61.5%/yr)FEMY compounded faster over this window
Log scale — wide-divergence pair
ENSC FEMY
ENSC vs FEMY: by the numbers
- •ENSC is the larger company ($7M vs $6M market cap).
- •Both run net losses; FEMY's is the smaller (-534.27% vs -1084.23% net margin).
Metrics side by side
Valuation
| Metric | ENSC | FEMY |
|---|---|---|
| P/S ratio | 5.67 | 2.72 |
| P/B ratio | N/A | 1.55 |
Profitability
| Metric | ENSC | FEMY |
|---|---|---|
| Gross margin | 0.00% | 61.96% |
| Operating margin | 0.00% | -763.90% |
| Net margin | -1084.23% | -534.27% |
| ROE | N/A | -304.78% |
| ROIC | N/A | -209.05% |
Growth (annualized)
| Metric | ENSC | FEMY |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.97% |
| Total return CAGR (5Y) | -86.22% | -57.27% |
Frequently asked
- How have ENSC and FEMY total returns compared?
- Over the past 5 years, ENSC delivered -86.22% and FEMY delivered -57.27% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.